4//SEC Filing
Walker Karen Marie 4
Accession 0000950170-25-054342
CIK 0001994702other
Filed
Apr 14, 8:00 PM ET
Accepted
Apr 15, 5:40 PM ET
Size
7.3 KB
Accession
0000950170-25-054342
Insider Transaction Report
Form 4
Walker Karen Marie
Chief Technology Officer
Transactions
- Award
Stock Option (right to buy)
2024-04-11+80,000→ 80,000 totalExercise: $2.06Exp: 2035-04-11→ Common Stock (80,000 underlying) - Award
Common Stock
2025-04-11+13,000→ 22,636 total
Footnotes (2)
- [F1]Represents a restricted stock unit award of common stock, 1/4th of which shall vest on April 11, 2026, and 1/4th of which shall vest on each one-year anniversary thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.
- [F2]1/4th of the shares subject to the option shall vest on April 11, 2026, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.
Documents
Issuer
Kyverna Therapeutics, Inc.
CIK 0001994702
Entity typeother
Related Parties
1- filerCIK 0002008556
Filing Metadata
- Form type
- 4
- Filed
- Apr 14, 8:00 PM ET
- Accepted
- Apr 15, 5:40 PM ET
- Size
- 7.3 KB